Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 21, 2019; 25(43): 6373-6385
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6373
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6373
n | Tumor | FLR in mL | Hypertrophy | Kinetic growth in %/d | Severe Cx, ≥ IIIB | PHLF, 50-50 | 90-d mortality | |||
Stage I | Stage II | Absolute in mL | Relative in % | |||||||
Case control | ||||||||||
D'Haese et al[38], 2016 | 35/225 | HCC/CRLM | 420 (346-540)/340 (260-433) | 639 (541-855)/617 (487-724) | 206 (172-277)/252 (186-348) | 47 (26-69)/76 (50-108) | 4.7 (2.8-8.9)/9.1 (5.8-14.3) | 14 (27)/54 (17) | 14 (40)/42 (19) | 11 (31)/15 (7) |
Chia et al[43], 2018 | 9/4 | HCC/non-HCC | 381 (280-422)/313 (177-550) | - | 154 (86-166)/251 (248-344) | 40 (22-65)/138 (92-139) | 19 (6-24)/35 (31-39) | 1 (14)/0 | 2 (29)/1 (25) | 1 (11)/0 |
- Citation: Au KP, Chan ACY. Current status of associating liver partition with portal vein ligation for staged hepatectomy: Comparison with two-stage hepatectomy and strategies for better outcomes. World J Gastroenterol 2019; 25(43): 6373-6385
- URL: https://www.wjgnet.com/1007-9327/full/v25/i43/6373.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i43.6373